Insights in Public Health: Ambulatory Blood Pressure Monitoring: Underuse in Clinical Practice in Hawai'i
- PMID: 29164016
- PMCID: PMC5694975
Insights in Public Health: Ambulatory Blood Pressure Monitoring: Underuse in Clinical Practice in Hawai'i
Abstract
Hypertension is one of the leading causes of death and disability worldwide. Blood pressure reduction and control are associated with reduced risk of stroke and cardiovascular disease. To achieve optimal reduction and control, reliable and valid methods for blood pressure measurement are needed. Office based measurements can result in 'white coat' hypertension, which is when a patient's blood pressure in a clinical setting is higher than in other settings, or 'masked' hypertension, which occurs when a patient's blood pressure is normal in a clinical setting, but elevated outside the clinical setting. In 2015, the US Preventative Services Task Force recommended Ambulatory Blood Pressure Monitoring (ABPM) as the "best method" for measuring blood pressure, endorsing its use both for confirming the diagnosis of hypertension and for excluding 'white coat' hypertension. ABPM is a safe, painless and non-invasive test wherein patients wear a small digital blood pressure machine attached to a belt around their body and connected to a cuff around their upper arm that enables multiple automated blood pressure measurements at designated intervals (typically every 15 to 30 minutes) throughout the day and night for a specified period (eg, 24 hours). Patients can go about their typical daily activities wearing the device as much as possible, except when they are bathing, showering, or engaging in heavy exercise. Given the importance of blood pressure monitoring and control to population public health, this article provides details on the relevance and challenges of blood pressure measurement broadly then describes ABPM generally and specifically in the Hawai'i context.
Similar articles
-
Implementing ABPM into Clinical Practice.Curr Hypertens Rep. 2018 Feb 5;20(1):5. doi: 10.1007/s11906-018-0805-y. Curr Hypertens Rep. 2018. PMID: 29404785 Review.
-
Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring.Blood Press Monit. 1999 Dec;4(6):319-31. doi: 10.1097/00126097-199912000-00005. Blood Press Monit. 1999. PMID: 10602536 Review.
-
[2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].Clin Investig Arterioscler. 2013 Apr-Jun;25(2):74-82. doi: 10.1016/j.arteri.2013.03.002. Epub 2013 Apr 30. Clin Investig Arterioscler. 2013. PMID: 23849214 Spanish.
-
Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Dec. Report No.: 13-05194-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Dec. Report No.: 13-05194-EF-1. PMID: 25632496 Free Books & Documents. Review.
-
Status of ambulatory blood pressure monitoring and home blood pressure monitoring for the diagnosis and management of hypertension in the US: an up-to-date review.Hypertens Res. 2023 Mar;46(3):620-629. doi: 10.1038/s41440-022-01137-2. Epub 2023 Jan 5. Hypertens Res. 2023. PMID: 36604475 Free PMC article. Review.
Cited by
-
Advances in Non-Invasive Blood Pressure Monitoring.Sensors (Basel). 2021 Jun 22;21(13):4273. doi: 10.3390/s21134273. Sensors (Basel). 2021. PMID: 34206457 Free PMC article. Review.
-
Advancement in the Cuffless and Noninvasive Measurement of Blood Pressure: A Review of the Literature and Open Challenges.Bioengineering (Basel). 2022 Dec 24;10(1):27. doi: 10.3390/bioengineering10010027. Bioengineering (Basel). 2022. PMID: 36671599 Free PMC article. Review.
References
-
- Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133(4):e38–e360. - PubMed
-
- Centers for Disease Control, author. WISQARS Leading Cause of Death Reports, National and Regional. 2010. [June 15, 2017]. https://webappa.cdc.gov/sasweb/ncipc/leadcaus10_us.html.
-
- Hawaii State Department of Health, author. Hawaii's Plan for the Prevention of Heart Disease and Stroke 2011–2016. Honolulu, HI: Hawaii State Department of Health, Heart Disease and Stroke Prevention Program; 2011. [June 30, 2017]. https://health.hawaii.gov/heart-disease-stroke/files/2013/12/HDSP_Plan.pdf.
-
- Smith SC, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2011 Nov 29;58(23):2432–2446. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources